Healthcare costs are a top concern across the United States, with 2025 anticipated to be the most expensive year for employer-sponsored insurance yet. Employers are expected to face an 8 to 9% ...

Regeneron Pharmaceuticals’ $256 million offer was chosen the winner of 23andMe’s bankruptcy auction. Drug research never ...

The law that created ASTP as a formal federal agency gave it duties such as supporting a more effective marketplace and greater competition. Stephen Konya, ASTP’s chief, innovation and strategic ...

Threat actors continue to refine their strategies, and the financial incentives for cybercrime persist. However, the combination of stronger defenses, regulatory pressure, and industry collaboration ...

From AI to value-based care, three VCs shared their controversial takes on healthcare during a recent panel discussion at the MedCity INVEST conference.

WeightWatchers has long been a household name, boosted by celebrity endorsements from Oprah Winfrey and Jennifer Hudson. Jean Nidetch founded the New York City company in her apartment in the ...

The decision to withdraw more than $11 billion in public health funding, including support for substance use disorder and mental health programs, is a stark reminder of how fragile our nation’s ...

Alzheimer’s disease is currently diagnosed with expensive medical imaging or invasive methods that require a spinal tap. Patients now have an alternative. The FDA has cleared a new Fujirebio ...

Clinical research sites face an information challenge that hinders efficiency and collaboration. As trial complexity increases, the multiple logins, devices, and spreadsheets site staff use to ...

Digital transformation within healthcare, especially the life sciences sector, is alive and well and currently driven by the ongoing expansion of artificial intelligence, inclusive of generative ...